Clinical and neuropathological picture of familial encephalopathy with bifunctional protein deficiency by Paprocka, Justyna et al.
Original article
Clinical and neuropathological picture of familial encephalopathy 
with bifunctional protein deficiency
Justyna Paprocka1, Ewa Jamroz1, Dariusz Adamek2, Teresa J. Stradomska3, Ewa Gtuszkiewicz1,
Urszula Grzybowska-Chlebowczyk4, Elżbieta Marszat1
'Child Neurology Departm ent, M edical University of Silesia, Katowice, Poland; 'Neuropathology Department, Neurology Institute, 
M edical College, Jagiellonian University CMUJ, Kraków, Poland; 'Laboratory and D iagnostics Department, The Children's M emorial 
Health, Institute, Warsaw, Poland; 4Paediatric Departm ent, Gastroenterology Unit, M edical University of Silesia, Katowice, Poland
Folia Neuropathol 2007; 45 (4): 213-219
A b s t r a c t
Peroxisomal diseases are a heterogeneous group o f genetic metabolic disorders which are caused by incorrect 
biogenesis o f peroxisomes or a defect in activity o f particular enzymes located in those organelles.
D-bifunctional protein (D-BP) deficiency belongs to the second group o f peroxisomal diseases characterised by 
dysfunction o f a single peroxisomal enzyme. Bifunctional protein is a catalyst in the second and third stage o f the 
ß-oxidation o f fatty acids. Gene locus o f bifunctional protein deficiency comprises chromosomes 5q2 and 3p23-p22. 
The authors present two siblings with progressing family encephalopathy. In the younger brother the diagnosis of 
a bifunctional protein deficiency was made. The girl died before a diagnosis was made; however, due to the presence 
o f a very similar clinical condition a suspicion arises that the girl had a peroxisomal disease. In the siblings were 
ascertained characteristic dysmorphic features, delayed psychomotor development, polymorphic epileptic seizures 
and generalized muscular hypotonia with areflexia.
The neuropathological findings were consistent in general with MRI findings showing features o f hypomyelination. 
Also neuron heterotopias that were found in autopsy are a form o f pathology typical for D-BP.
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Introduction
Peroxisomal diseases form a heterogeneous gro­
up of genetically conditioned metabolic diseases that 
occur as a result of abnormal biogenesis of peroxiso­
mes or defects in the activity of enzymes localized 
in these organelles. Except for X-linked adrenoleuko- 
dystrophy (ALD) all peroxisomal diseases are inheri­
ted in an autosomal recessive way. Their prevalence 
varies within the range 1:25000 to 1:50000 [4-6].
Peroxisomal enzymes are involved in oxidation of 
very long-chain fatty acids (VLCFA), in bile acid me­
tabolism, in pipecolic and phytanic acid degradation, 
plasmalogen synthesis and in intracellular neutrali­
zation of peroxides.
Recently peroxisomal diseases can be classified 
into three groups [6]:
- the first group caused by disorders in peroxisome 
biogenesis (absence or deficiency) accompanied 
by numerous enzymatic defects (Zellweger spec-
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trum (ZS), neonatal adrenoleukodystrophy (NALD), 
infantile Refsum's disease (IRD));
- in the second group the structure of peroxides is 
normal, only one peroxisomal enzyme is deficient 
(bifunctional protein deficiency, X-linked adreno­
leukodystrophy, acatalasemia, hyperoxaluria type 1, 
pseudo-Zellweger syndrome, Acyl-Coa deficiency);
- the third group includes diseases with changes 
in peroxisome structure and enzymatic defects 
(pseudo-Zellweger syndrome, rhizomelic chondro­
dysplasia punctata).
Patient presentation 
Patient NM
11-month girl born to healthy, unrelated parents. 
The child from a normal first pregnancy, born after 
39 weeks of gestation by Caesarean section (indica­
tion: breech presentation of the fetus), with birth we­
ight of 3500 g, Apgar score -  8 points. On admission 
physical examination revealed dysmorphic features, 
systolic cardiac murmur. Neurological examination: 
head circumference (HC) -  46.5 cm (90-97 pc), hori­
zontal nystagmus, opsoclonia, hypotonia with arefle­
xia, poor spontaneous motor activity. Psychomotor 
development of the child estimated at 1 month.
Table I. Gestation and delivery period
Patient NM Patient NW
(11 mo) (6 mo)
pregnancy normal normal
delivery caesarean caesarean
section section
birth weight 3500 g 3250 g
birth head circumference 37 cm 35 cm
Apgar score 8 points 10 points
From the first day of her life the patient suffered 
from respiratory distress and polymorphic epileptic 
seizures. For epilepsy treatment phenobarbital, va l­
proic acid and carbamazepine were administered. At 
the age of 2 months MRI of the head demonstrated 
changes suggesting demyelinization of white matter 
of CNS, w idening of the cerebral ventricular system 
and basal cisterns. All in all the results of MRI exa­
mination were consistent with or at least strongly 
suggestive of leukodystrophy. The findings of the re­
m aining additional tests are presented in Table I. The 
girl died at 14 months of age.
In the autopsy examination, the white matter sho­
wed gently and not uniformly lowered consistency. 
The ventricular system was broadened. There were 
no macroscopic unequivocally evident morphologi­
cal changes. For the histopathological investigations 
samples taken from the lobes of the brain, basal gan­
glia, thalamus, cerebellum and brain stem were typi­
cally processed to the paraffin blocks. The slides were 
stained with haematoxylin-eosin (HE), Kluver-Barrer 
(KB) method, and immunohistochemically with an­
tibody against glial fibrillary acidic protein -  GFAP 
(1:100). Antibodies for GFAP and other reagents for 
immunohistochemistry were purchased in DAKO.
The following neuropathological changes were 
found. In the white matter of the brain and cere-
Table II. Clinical picture of the patients
Patient NM Patient NW
(11 mo) (6 mo)
respiratory distress since 1st day of life
since 1st day of 
life
epileptic seizures polymorphic (Pb, VPA, CBZ)
polymorphic 
(Pb, VPA, CBZ, 
NZP)
psychomotor delay at the level of 1st month of life
at the level of 
the 1st day of life
Table III. Results of additional tests
Patient NM (11 mo) Patient NW (6 mo)
cerebrospinal fluid normal normal
EEG generalized paroxysmal changes (with right parietal area predominance) generalized paroxysmal changes
ENG, EMG myopathic pattern decreased conduction velocity 26.4 m/s
ophthalmological examination normal except for horizontal nystagmus -  normal
cardiologic evaluation pulmonary hypertension normal
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bellum there were features of hypomyelination m a­
nifesting as poorly bordered areas of “paleness” in 
slides stained with KB (Fig. 1). The level of severity 
of hypomyelination was not uniform. Noticeably in 
subcortical zones the white matter was almost nor­
mally myelinated. In the whole white matter more 
or less intensive gliosis was noted (Fig. 2). G liosis in 
the white matter is formed by astrocytes only mildly 
hypertrophic with few and short processes (Fig. 2). 
This is in contrast with gliosis observed in the grey 
matter in the brain cortex and basal ganglia where 
astrocytes are strongly hypertrophic (large, with am-
Fig. 1  Cerebral white matter. The zone of imper­
fect myelination is seen (poorly bordered “pale­
ness”). KB method. Macroscopic photograph
Fig. 3. Grey matter of cerebral cortex -  gliosis with 
strongly hypertrophic astrocytes (large sized with 
ample perinuclear cytoplasm and with numerous 
long processes) especially densely surrounding 
blood vessels. GFAP IHCh. Magn. x 200
ple perinuclear cytoplasm), rich in long processes, and 
especially numerous around vessels, som etim es as if 
“encrusting” them (Fig. 3). G liosis w as also noted in 
the cerebellum, especially in the (internal) granular 
layer of the cortex (Fig. 4). In turn, in the molecular 
layer of the cerebellar cortex strongly GFAP-immu- 
nopositive cell processes formed a “ palisade-like” 
structure (Fig. 4). They supposedly represent embry­
onic radial glia and their presence (as well as the
Fig. 2. Gliosis in cerebral white matter with re­
latively few and only mildly hypertrophic astro­
cytes with scanty processes. GFAP IHCh. Magn. 
x 200
Fig. 4. GFAP-positive “palisade-like” formation in 
molecular layer of cerebellar cortex supposedly 
representing embryonic radial glia seems to be 
a feature of delayed maturation of cerebellum. 
In the internal granular layer of the cerebellar 
cortex there are numerous hypertrophic reactive 
astrocytes. GFAP IHCh. Magn. x 200
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remnants of external granular layer -  see Fig. 10) 
reflects improper (delayed) maturation. Neurons in 
the brain cortex showed marked but not specific de­
generative changes with prominent but probably to 
some degree artifactual perineuronal vacuolisation 
(Fig. 5). Focally in the brain cortex some cells with 
“em pty” nuclei were noted (Fig. 6). These cells may 
be degenerated neurones but at least some of them 
may represent so-called Alzheim er type II cells. Pur­
kinje cells of cerebellar cortex showed marked featu­
res of degeneration of various morphology (Fig. 7). 
It seems that the most striking and interesting were 
the multiple foci of neuronal heterotopias that were
found first of all in the cerebellum but sporadically 
also in the cerebrum. In the cerebellum the hetero­
topias had the form either of large clusters of cells 
morphologically equivalent to Purkinje cells or even 
singular cells misplaced into white matter (Figs. 8, 9). 
In the molecular layer of the cerebellar cortex the 
number of cells w as focally increased and there 
were numerable remnants of the external granular 
layer (Fig. 10). It seems that these findings could 
be interpreted as the m anifestation of improper or 
“incomplete” migration of neuroblasts from the fe­
tal external granular layer. Moreover, here and the­
re some sm all cerebellar “ pseudofolia” suggesting
Fig. 5. Non-specific degeneration of neurons in 
neocortex. There is marked vacuolisation in neu­
ropil especially around neurons (probably par­
tially artifactual). KB method. Magn. x 200
Fig. 7. Degeneration of Purkinje cells in cerebel­
lar cortex. HE. Magn. x 100
Fig. 6. Cells in cerebral cortex (molecular layer) 
with “empty” nuclei (one of them marked with 
an arrow) supposedly consistent with “Alzhei­
mer type II cells”. HE. Magn. x 200
Fig. 8. Cluster of heterotopic Purkinje cells in 
white matter of cerebellum. HE. Magn. x 200
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Fig. 9. Two heterotopic Purkinje cells in white 
matter of cerebellum. HE Magn. x 100
cerebellar microgyria were noted. Also the cerebral 
cortex focally showed disordered architecture.
Fig. 10. Increased number of cells in molecular 
layer of cerebellar cortex. Remnants of the exter­
nal granular layer are also seen. It seems that 
these findings suggest improper (“unfinished”) 
migratory process of the cells from the external 
granular layer. HE. Magn. x 100
Patient NW
6-month boy (brother of the NM patient) from a 
normal second pregnancy, born in 40th week, with 
body weight of 3250 g by Caesarean section, Apgar 
score -  10 points. In the boy, sim ilarly to his sister, 
from the first day of his life respiratory distress and 
generalized muscular hypotonia accompanied with 
areflexia were observed.
The first epileptic seizures appeared in the neo­
natal period as left-sided focal seizures, myoclonus 
and tonic seizures. Valproic acid and phenobarbital 
were adm inistered in the first stage of the treat­
ment and tem porary control of seizures w as obta­
ined. Due to the reintensification of polymorphic 
epileptic seizures and the appearance of cluster 
seizures (requiring hospitalization at an intensive 
care unit), epilepsy treatm ent was modified (inclu­
ding Clonazepam) with a satisfactory effect. In the 
MRI of the head performed in the 3rd month of life 
dysm yelination in the area of the occipital lobes 
w as demonstrated.
On adm ission physical examination revealed: 
hypotrepsia, dysmorphic features, systolic cardiac 
murmur. The neurological evaluation showed: head 
circumference HC-45 cm (90-97 pc) the presence of 
posture reflexes, generalized muscular hypotonia, 
lack of tendon reflexes, marked atrophy of distal mu­
scle groups and very poor spontaneous motor activi­
ty. Psychomotor development was estimated at one 
month of age.
In the control MRI examination of the head at 
6 months of age no progression of myelinization 
process was revealed. The result of the cerebrospinal 
fluid examination was normal.
Based on metabolic work-up we excluded amino- 
acidopathies, organic acidurias, lactic acidosis, lyso­
somal storage disorders, mitochondrial diseases and 
urea cycle disorders.
Suspecting NALD serum VLCFA levels were de­
termined, revealing abnormal results. In order to 
establish a final diagnosis the levels of VLCFA, pla- 
smogens and pipecolic acid were determined in the 
cultures of skin fibroblasts and also immunocytoche- 
mical analysis of peroxisomes was performed. The 
results of the above-mentioned tests suggested the 
lack of a single enzyme -  bifunctional protein. The 
C (carbon) concentration 26:0; C 26:1 and the pro­
portion C24/C22 and C26/C22 were elevated, which 
indicated the defect of peroxisomal oxidation of fat­
ty acids (VLCFA in serum: C26:0 3.150 ug/ml, normal 
values: 0.24±14; C26:1 2.93 ug/ml, normal values: 
0.11±0.04; C24:C22 1.576 normal values: 0.78±0.1; 
C26:C22 0.21, normal values: 0.01±0.003; VLCFA in 
fibroblasts: C26:0 0.469 ug/mg protein, normal va­
lues: 0.07±0.04, C26:1 0.506 ug/mg protein, normal 
values: 0.09±0.07; C26:0/C22:0  0.848, normal values:
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0.08±0.03). Phytanic acid oxidation was diminished: 
4.175 pmol/h/mg protein (normal values: 13.2). On 
the basis of immunocytochemical analysis of pero­
xisom es the presence of ALDP and protein catalase 
was established.
Eventually, D-bifunctional protein deficiency was 
diagnosed with features of encephalopathy. The 
child died at 18 months of age. Due to the lack of 
consent of his parents postmortem examination was 
not performed.
Discussion
Structural analysis of bifunctional protein reve­
aled the presence of three domains: the N-terminal 
domain (1-323 amino acids) which bears the 3-hy- 
droxyacyl-CoA dehydrogenase activity, the central 
domain (324-595 amino acids) which shows 2-enoyl- 
-CoA hydratase activity, and the C-terminal domain 
(597-737 amino acids) which presents a great degree 
of homology to the sterole transfer protein and cata­
lyzes in vitro the transit of 7-dehydrocholesterol and 
phosphatydylcholine through cellular membranes [4]. 
Depending on the localization of a molecular defect 
patients with D-bifunctional protein deficiency (D-BP, 
D-bifunctional protein deficiency, OMIM#261515) can 
be divided into three groups: as patients with the de­
hydrogenase and hydratase complex defect or with 
isolated defects of the enzymes mentioned. D-bifunc- 
tional protein deficiency m aybe caused by a mutation
in the HSD187D4 gene. The gene locus includes 5q2 
[6]. The bifunctional protein exists in two isomers: 
L and D. A significant difference lies in the specificity 
towards the substrate. Only the D-bifunctional pro­
tein catalyzes the creation process of ketoacyl-CoA 
derivatives from straight chain as well as branched 
chain fatty acids. Similarly, dicarboxylic fatty acids 
undergo ß -oxidation not within mitochondria, as it 
had previously been believed, but among others, due 
to the presence of D-bifunctional protein [2].
The patient presented in this paper is a rare case 
of an isolated defect of peroxisomal fatty acid oxi­
dation. A very sim ilar clinical picture in his sister 
suggests the presence of a peroxisomal disease in 
the girl. The basic diagnostic difficulty lies in the dif­
ferentiation between a great number of chronic di­
seases accompanied by hypotonia, epileptic seizures 
and dysmorphic features. Very often patients with 
peroxisomal diseases do not present with the full 
spectrum of the disease. According to Poll-The and 
Saudubray peroxisomal disorders may be clinical­
ly diagnosed based on the presence of dysmorphy, 
neurological symptoms and renal and hepatic dys­
function [6].
In peroxisomal diseases, am ong other metabolic 
diseases, epileptic seizures appear relatively often. 
Focal seizures, for example, occur in 80%  of Zellwe­
ger syndrome patients, whereas generalized seizures 
and myoclonia are observed as early as in the neo­
natal period. Similarly, in NALD tonic seizures and 
myoclonia are accompanied by hypsarrhythmia in an 
EEG tracing [1,2,6].
Am ong neurological sym ptom s encephalopathy, 
seizures, hypotonia and neuropathy are of primary 
importance, whereas during the ophthalmological 
examination quite often retinopathy, optic dysplasia 
and cataract can be observed. The first symptoms 
are usually not accompanied by metabolic decom ­
pensation features [6,7,8]. Peroxisomal diseases 
most frequently demonstrate themselves as chronic 
encephalopathy with its onset in infancy or alternati­
vely in early childhood or as progressive neurological 
disorders at school age. According to recent studies 
the clinical course of the disease is more severe in 
patients with D-bifunctional protein deficiency in 
comparison to the remaining entities from the same 
group. Neuroimaging studies of BPD dem onstra­
te disturbed white matter myelinization (mainly in 
occipital lobes and the cerebellum), neuronal m igra­
tion disorder (most frequently polymicrogyria), focal
Table IV. Biochemical markers in peroxisomal 
disorders
Analysis Results
routine clinical 
chemistry
i  cholesterol, i  glucose, t  transami­
nases, t  serum iron, t  transferrin (in 
plasma or serum)
very long chain 
fatty acids
t t t  (in plasma, serum or cultured 
fibroblasts)
ratio of C26/C22 t t t
plasmalogens i i  ( in whole blood or erythrocyte 
membranes)
phytanic and 
pristanic acids
t  (in plasma or serum, levels dependent 
on dietary intake)
bile acids t  individual metabolites (differentiation 
in plasma or urine)
pipecolic acid t  (in plasma, urine or bile by GC/MS)
organic acids dicarboxylic aciduria, often characteri­
stic t  of 2-hydroxysebacic acid
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heterotopias, dysplasia of inferior olives, and peri­
ventricular cysts. The MR image resembles lesions 
found in NALD and ALD. The neuropathological fin­
dings in child NM were consistent in general with 
MRI findings showing features of hypomyelination. 
Also neuron heterotopias that were found in autop­
sy are a form of pathology typical for D-BP [6]. As 
was shown especially in Fig. 4 and Fig. 10 the neuro- 
pathological findings in the cerebellum suggest the 
impairment of its development probably with the de­
fect of migration and maturation of neurons derived 
from the external granular layer. Another interesting 
finding seems to be the apparent occurrence of two 
types of gliosis: in white matter formed by rather 
“slim ” astrocytes, and in grey matter composed of 
large, markedly hypertrophic ones. The biochemical 
marker for bifunctional protein deficiency is the in­
crease of serum VCLFA levels and fibroblast VCLFA 
levels as well as the increase in concentrations of 
acid bile metabolites (Table IV).
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